N-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease or congestive heart failure
US6602905B1 · kind B1 · utility
8Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2002 |
| Grant date | Aug 5, 2003 |
| Priority date | — |
| Expiry date | Aug 21, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having anti-fibrotic effects are provided. Also provided is a method for treating disorders, diseases or conditions associated with pathological fibrotic states. The compounds useful in the present invention are homocysteine thiolactone and selected derivatives thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.